Announcement
BUHLMANN Diagnostics Corp is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay on their clinical chemistry AU series analyzers (AU480, AU680, AU5800, and DxC 700 AU).
Benefits of this Collaboration
Directly applying the fCAL® turbo and fPELA® turbo on Beckman analyzers streamlines testing procedures for modern core labs, providing rapid and reliable results with minimal hands-on time.
Rollout
How will the rollout of this collaboration be managed, especially for existing customers?
The rollout plan depends on the initiative of local Beckman Coulter affiliates. Existing customers established on those analyzers will continue to be served by BUHLMANN Diagnostics Corp.
Is this available in the US?
The product launch was in September 2024. Now available in the US!
Quick Connect
Assays
- fCAL® turbo (calprotectin) assay and fPELA® turbo (pancreatic elastase) assay are now available:
- US & Outside the US:
- AU Series analyzers (AU480, AU680, AU5800)
- DxC 700 AU
- US & Outside the US:
CALEX® Cap Stool Preparation Device
CALEX® Cap Stool Preparation Device: Additionally, combining both assays with the BÜHLMANN CALEX® Cap for Total Laboratory Automation (TLA) minimizes the complexity of sample processing (apply directly on analyzers). The device is designed to optimize stool extraction efficiency, helping to maximize sample stability and yield, and ultimately delivering robust, reliable, and accurate results for both fecal calprotectin and pancreatic elastase testing (one sample for two assays).
